MySimplePetLab
MySimplePetLab is a private pet health startup that sells at-home diagnostic testing kits for dogs and cats via direct-to-consumer online channels, targeting US pet owners seeking convenient wellness screening without veterinary clinic visits.
- Company typePrivate
- Founded2019
- HeadquartersCentennial, United States
- Headcount11–50
- GTM typeB2C
- OfferingHardware or Manufacturing
What MySimplePetLab does
MySimplePetLab Inc. is a private, venture-backed pet health company founded in 2019 and headquartered in Centennial, Colorado (Delaware-incorporated), focused on at-home diagnostic testing for dogs and cats. Its core product is a portfolio of at-home pet health diagnostic kits that enable pet owners to perform routine health screening and wellness monitoring without a veterinary clinic visit. The kits are sold direct-to-consumer online, with stated plans to extend distribution into physical retail stores and to broaden the product line beyond the initial dog and cat offerings, alongside ambitions to build nationwide testing and data-sharing infrastructure.
The company operates a one-time-sale revenue model on individual diagnostic kits, targeting pet owners as its primary persona and positioning itself as improving pet healthcare accessibility and veterinary clinic efficiency. It has raised approximately $9.65 million+ across multiple SEC-registered exempt offerings between 2022 and 2024, most notably a $5 million Series A in November 2022 led by Mars Companion Fund / Mars Venture Fund (Mars Petcare-affiliated). The firm employs 11-50 people and has no disclosed named customers, enterprise contracts, or recurring subscription layer. Public information does not disclose pricing, gross margins, revenue, AI/ML capabilities, patents, or executive leadership detail, which materially limits visibility into unit economics and operating performance.
MySimplePetLab firmographics
Firmographics- Name
- MySimplePetLab
- Legal name
- MySimplePetLab Inc.
- Website
- https://mysimplepetlab.com
- Company type
- Private
- Founded year
- 2019
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- MySimplePetLab is a private pet health startup that sells at-home diagnostic testing kits for dogs and cats via direct-to-consumer online channels, targeting US pet owners seeking convenient wellness screening without veterinary clinic visits.
- Ownership category
- akta.pro rank
MySimplePetLab industry classification
Industry- Product category
- Pet Health Diagnostics
- NAICS
- Medical and Diagnostic Laboratories (62151), Medical Laboratories (621511)
- SIC
- In Vitro & In Vivo Diagnostic Substances (2835), Services-Medical Laboratories (8071)
- akta.pro primary industry
- Point-of-Care & In-Clinic Diagnostics (Rapid Tests, Benchtop Analyzers) (HLAMADAI)
Keywords
Where MySimplePetLab is headquartered
LocationHeadquarters
- HQ city
- Centennial
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
MySimplePetLab business model
Business model- GTM type
- B2C
- Offering type
- Hardware or Manufacturing
- Cost components
- Supply Chain, Operations, Personnel, Technology or R&D, Marketing or Sales
Revenue model
- Pet Diagnostic Testing Kits: Sale of at-home diagnostic testing products for pets (dogs and cats) enabling health screening and wellness monitoring without veterinary clinic visits
Go-to-market motion1 record
Distribution channels2 records
MySimplePetLab product offering
Product offeringCore offering
MySimplePetLab provides at-home pet health diagnostic testing kits for dogs and cats, enabling pet owners to conduct health screenings and wellness monitoring without visiting a veterinary clinic. The company supplies the tests, diagnostic technology, laboratory processing, operations, and results to deliver simple pet care from home or in-clinic. It sells its own branded diagnostic kit products directly to pet owners and intends to expand into retail distribution.
Product overview
MySimplePetLab offers a portfolio of at-home pet health diagnostic testing products, including testing kits designed for dogs and cats. The company operates as a pet health startup focused on improving pet wellness accessibility through home-based testing solutions that enable pet owners to conduct health assessments without requiring immediate veterinary visits. The company has raised Series A funding to expand its testing services and technology infrastructure.
Differentiator
Problem solved
Functional benefit
Products and services
- At-Home Pet Health Tests At-home diagnostic testing kits for dogs and cats that allow pet owners to conduct health tests without visiting a veterinarian, with plans to enhance nationwide testing and data sharing capabilities.
- Home Testing Kits (Retail Line) Retail-packaged home testing kits for dogs and cats designed to improve pet healthcare accessibility and veterinary clinic efficiency, with planned in-store distribution and product line expansion.
Quantifiable outcome
- Improved pet healthcare accessibility through at-home testing
Companies that use MySimplePetLab
Customer profileSegments1 record
Ideal customer profiles2 records
MySimplePetLab technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature1 record
MySimplePetLab partnerships and signals
Strategic signalScale indicators4 records
Recent moves6 records
Expansion highlights4 records
MySimplePetLab competitors and assessment
Company assessmentBroad incumbents
- Zoetis: Global animal health leader with diagnostics, devices, and pharmaceuticals across companion and livestock; relevant incumbent across the pet diagnostics value chain, now including Basepaws.
- IDEXX Laboratories: Dominant veterinary diagnostics company providing in-clinic analyzers and reference lab services; sets the standard for pet diagnostic accuracy that MySimplePetLab's at-home kits must meet.
- Antech Diagnostics: Mars Petcare-owned veterinary reference laboratory network; the strategic relationship between Antech's parent (Mars) and MySimplePetLab makes this both a peer and a channel partner.
Emerging players
- Petriage: Telehealth and at-home care platform for pets that incorporates remote symptom triage and may integrate or compete with at-home diagnostic testing flows.
- PetDx: Developer of liquid biopsy (OncoK9) for cancer detection in dogs; overlaps with MySimplePetLab's diagnostic focus on dogs but operates in a higher-acuity, vet-channel-delivered niche.
- Vetster: Online veterinary telehealth marketplace; an adjacent digital pet care company reshaping access to veterinary advice alongside at-home diagnostic offerings.
Direct peers
- Orivet: Pet genetic testing and wellness plans, particularly in Australia/US; comparable DTC genetic and health screening offerings targeted at pet owners and breeders.
- Basepaws (Zoetis): At-home cat and dog genetic and oral health test kits, now owned by Zoetis; competes head-to-head with MySimplePetLab in the DTC pet health testing category.
- Embark Veterinary: Direct-to-consumer dog genetic and health testing brand; competes for the same dog-owner attention with at-home saliva/swab kits and online results portal.
- Wisdom Panel: Long-established at-home pet DNA and health screening brand owned by Mars Petcare; the most direct analogue and benchmark for MySimplePetLab's at-home testing model.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat3 records
Key risks5 records
Key highlights5 records
Customer concentration
MySimplePetLab social profiles
Digital presenceMySimplePetLab financial estimates
Financial estimateRevenue estimate
Valuation estimate
MySimplePetLab leadership team
Management profileNumber of profiles
MySimplePetLab funding detail
Funding detailFunding overview
Funding rounds4 records
Investors1 record
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
MySimplePetLab M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about MySimplePetLab
What does MySimplePetLab do?
MySimplePetLab provides at-home pet health diagnostic testing kits for dogs and cats, enabling pet owners to conduct health screenings and wellness monitoring without visiting a veterinary clinic. The company supplies the tests, diagnostic technology, laboratory processing, operations, and results to deliver simple pet care from home or in-clinic. It sells its own branded diagnostic kit products directly to pet owners and intends to expand into retail distribution.
Is MySimplePetLab a public or private company?
MySimplePetLab is a private company. It is classified as venture growth investor backed and is currently operating.
When was MySimplePetLab founded?
MySimplePetLab was founded in 2019. It employs 11 to 50 people.
Where is MySimplePetLab based?
MySimplePetLab is headquartered in Centennial, United States, in the North America region.
How does MySimplePetLab make money?
One revenue line is on record: pet Diagnostic Testing Kits.
Who are MySimplePetLab's main competitors?
Broad incumbents on record are Zoetis, IDEXX Laboratories and Antech Diagnostics. Emerging players are Petriage, PetDx and Vetster. Direct peers are Orivet, Basepaws (Zoetis), Embark Veterinary and Wisdom Panel.
Does MySimplePetLab have an API?
No public API is recorded for MySimplePetLab.
What industry is MySimplePetLab in?
MySimplePetLab's product category is Pet Health Diagnostics. Its primary akta.pro industry code is HLAMADAI, Point-of-Care & In-Clinic Diagnostics (Rapid Tests, Benchtop Analyzers). Its NAICS code is 62151 and its SIC code is 2835.